It is the worst of times, it is the best of times—at least for Hungarian airline Wizz Air. WIZZ +3.22%
News that Pfizer's coronavirus vaccine was 90% effective in a trial gave aviation stocks a massive boost Monday. This is the kind of catalyst that could finally dim markets' love of technology shares and rekindle affection for sectors hit by Covid-19.
Yet many uncertainties still surround the vaccine and the economic impact of the pandemic. Given that U.S. and European airline stocks have already risen, respectively, 15% and 20% in one day—and were poised for big gains Tuesday as well—investors should think carefully before abandoning growth-related bets to embrace the aviation rally.
Wizz could be one corner of the market where they can fulfill both ambitions.
It remains the European carrier with the lowest unit costs—beating even Ireland's Ryanair —because of cheap labor and an increasingly modern fleet, notably including the Airbus A321, an elongated version of the workhorse A320 that fits more people. Wizz's core Eastern European market is poised to grow long-term as more people achieve middle-income status. And it also is unusually resistant to travel disruptions due to migration patterns within Europe: A whopping 65% of Wizz's passengers are typically traveling to visit friends and family.